Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer
Conclusions and clinical perspectives
Date
08 Oct 2016Session
Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancerPresenters
Solange PetersAuthors
S. PetersAuthor affiliations
- Centre Hospitalier Universitaire Vaudois, 1011 - Lausanne/CH
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Introduction
Presenter: Yuichiro Ohe
Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer
Resources:
Slides
Webcast
Treatment decisions at ALK TKI resistance
Presenter: Maurice Perol
Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer
Resources:
Slides
Webcast
Development of a nationwide genomic screening network for lung cancer with rare driver oncogenes and investigation of the mechanism of drug resistance
Presenter: Shingo Matsumoto
Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer
Resources:
Slides
Webcast